Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

por Keutzer, Lina, Mockeliunas, Laurynas, Sturkenboom, Marieke G. G., Bolhuis, Mathieu S., Akkerman, Onno W., Simonsson, Ulrika S. H.
Publicado 2023

Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling

por van Wijk, Rob C., Mockeliunas, Laurynas, Upton, Caryn M., Peter, Jonathan, Diacon, Andreas H., Simonsson, Ulrika S. H.
Publicado 2023

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

por van Wijk, Rob C., Mockeliunas, Laurynas, van den Hoogen, Gerben, Upton, Caryn M., Diacon, Andreas H., Simonsson, Ulrika S. H.
Publicado 2023

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

por Mockeliunas, Laurynas, Keutzer, Lina, Sturkenboom, Marieke G. G., Bolhuis, Mathieu S., Hulskotte, Lotte M. G., Akkerman, Onno W., Simonsson, Ulrika S. H.
Publicado 2022

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

por Mockeliunas, Laurynas, Faraj, Alan, van Wijk, Rob C., Upton, Caryn M., van den Hoogen, Gerben, Diacon, Andreas H., Simonsson, Ulrika S. H.
Publicado 2023

Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial

por Upton, Caryn M., van Wijk, Rob C., Mockeliunas, Laurynas, Simonsson, Ulrika S.H., McHarry, Kirsten, van den Hoogen, Gerben, Muller, Chantal, von Delft, Arné, van der Westhuizen, Helene-Mari, van Crevel, Reinout, Walzl, Gerhard, Baptista, Pedro M., Peter, Jonathan, Diacon, Andreas H.
Publicado 2022